1.9400 0.00 (0.00%)
Pre-Market: 7:27AM EDT
Previous Close | 1.8400 |
Open | 1.8000 |
Bid | 0.0000 x 1300 |
Ask | 2.1100 x 1000 |
Day's Range | 1.8000 - 2.0200 |
52 Week Range | 0.6300 - 6.5800 |
Volume | 145,248 |
Avg. Volume | 4,414,409 |
Market Cap | 168.212M |
Beta (5Y Monthly) | 1.58 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2500 |
Earnings Date | Feb 24, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Unless you borrow money to invest, the potential losses are limited. On the other hand, if you find a high quality...
BELGRADE, Mont., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT, the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it is not aware of any material, undisclosed corporate developments or material change in its business or affairs that has not been publicly disclosed that would account for the recent increase in the market price or trading volume of its shares. About Xtant Medical Holdings, Inc. Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant’s people are dedicated and talented, operating with the highest integrity to serve our customers. The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners. Investor Relations Contact David CareyLazar FINNPh: 212-867-1762 Email: david.carey@finnpartners.com
Xtant Medical (NYSEAMERICAN:XTNT) stock is surging higher on Friday even with there being a lack of news from the company today. Source: Bukhta Yurii / Shutterstock.com The jump in prices for XTNT stock comes at the same time that investors are taking an additional interest in its shares. As of this writing, more than 101 million shares of the stock have changed hands. That’s a hefty increase compared to its daily average trading volume of about 253,000 shares. So why exactly is XTNT stock up today? There’s a lot of chatter about the stock over on social media from day traders. It’s possible that these traders are boosting shares of the stock up higher to reap the profits when they sell.InvestorPlace - Stock Market News, Stock Advice & Trading Tips 8 Stocks to Buy for March Keeping that in mind, here’s what potential investors in XTNT stock need to know about the company. Xtant Medical a global medical technology company. It has a focus on designing, developing, and commercializing orthobiologics and spinal implant systems. These allow for spinal fusion in “complex spine, deformity and degenerative procedures.” Xtant Medical was founded in 2006 and operates out of its headquarters in Belgrade, Mont. It’s worth noting that the increasing interest in XTNT stock comes shortly after two major news announcements. Earlier this week, the company revealed results from its most recent earnings report. Then on Thursday, it announced the closing of a $20 million private placement. XTNT stock was up 162.7% as of Friday afternoon. On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next Potential Winner It doesn’t matter if you have $500 in savings or $5 million. Do this now. #1 Play to Profit from Biden's Presidency The post XTNT Stock: 7 Things to Know About Xtant Medical as Shares Rocket 150% appeared first on InvestorPlace.